16 February 2007

Solid progress during 2006

Cyprotex PLC ("the Company") confirms the release date for its 2006 preliminary results will be Thursday 15th March 2007. Following release of the preliminary results, Chairman and Chief Executive Officer, Mr Robert Morrisson Atwater, will be available to discuss progress made during 2006 and the outlook for 2007.

Cyprotex’s preliminary results will outline a further broad expansion of its customer base, which accelerated strongly during the second half of the year. These now number well in excess of 100 pharmaceutical companies, biotechs and CROs “Contract Research Organisations”, ranging from amongst the top ten global pharmaceutical companies to smaller specialised drug discovery groups.

As well as expanding its customer base, 2006 was also a year of reducing costs, whilst maximising operational gearing and the robustness of the company’s highly technical operations. Despite investment in its facilities, Cyprotex ended the year with a good cash reserve and recorded its first modest quarterly net profit during the final three months of 2006.

Cyprotex’s management looks to 2007 as a year of further significant progress.

For further information:

Cyprotex PLC
Robert Morrison Atwater, CEO
Tel: +44 1625 505 100
ir@cyprotex.com
www.cyprotex.com

or

Russell Gibbs, CFO
Tel: +44 1625 505 100
ir@cyprotex.com
www.cyprotex.com

Media Enquires:

WMC Communications
Charlie Geller/Alex Glover
Tel: +44 (0)20 7930 9030
charlie.geller@wmccommunications.com